Filter
482
Filtered Results: 482
Text search:
vials
Featured
Recommendations
78
New Publications
128
Language
Document type
No document type
225
Guidelines
122
Studies & Reports
43
Manuals
37
Fact sheets
21
Training Material
11
Infographics
10
Strategic & Response Plan
9
Situation Updates
3
Resource Platforms
1
Countries / Regions
India
57
Kenya
15
Ethiopia
14
Global
13
South Africa
11
Nigeria
9
Nepal
9
Zambia
9
Africa
9
Uganda
8
Philippines
8
Sierra Leone
7
Rwanda
7
Liberia
5
Ghana
5
Tanzania
5
Malawi
5
Latin America and the Carribbean
5
Congo, Democratic Republic of
4
Haiti
4
Pakistan
4
Syria
4
Zimbabwe
3
Argentina
3
Namibia
3
Eswatini/ Swaziland
3
Ukraine
3
West and Central Africa
3
Middle East and North Africa
3
Lebanon
2
Sudan
2
Botswana
2
Angola
2
Madagascar
2
Myanmar / Burma
2
Yemen
2
East and Southern Africa
2
Western and Central Europe
2
Russia
2
Guinea-Bissau
1
Morocco
1
Saudi Arabia
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Germany
1
Cambodia
1
Indonesia
1
Bangladesh
1
Mozambique
1
Central African Republic
1
Brazil
1
Greece
1
Libya
1
South–East Asia Region
1
Asia
1
Bhutan
1
Eastern Europe
1
Albania
1
Iran
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
191
Clinical Guidelines
83
Key Resources
33
Women & Child Health
27
Public Health
22
Pharmacy & Technologies
15
Capacity Building
13
Toolboxes
COVID-19
72
Pharmacy
56
Ebola
27
Rapid Response
23
NTDs
23
Caregiver
22
TB
17
AMR
17
Polio
14
HIV
10
Conflict
7
Cholera
6
NCDs
6
Planetary Health
5
Natural Hazards
4
Refugee
3
Disability
1
Zika
1
Mental Health
1
Specific Hazards
1
Health Financing Toolbox
1
Accessed 24 June 2014
AIDS Free Nigeria Training Manual
PURPOSE: To assess the appropriateness of computerizing a health facility warehouse. If users are interested in receiving technical assistance to improve and/or computerize the logistics information system, Management Sciences for Health (MSH) will analyze the responses to determine the initial step...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Since May 2019, Confirmation of 4 new emergence of type 2 vaccine-derived poliovirus (VDPV2) in Bambari (2) and Bimbo (2) health districts without any genetic link between them and other known viruses ; Bambari Health District: CAF-RS4-BAM-19-058, onset of paralysis: May 02, 2019. 07 positive contac...
Infectious diseases are constantly in transition. New diseases develop, known dis-eases become widespread or reemerge, and occasionally a disease is eradicated.Infectious diseases such as HIV, tuberculosis, and cholera are significant causes ofillness and death in many parts of the world. Health car...
SOP number: ICMR-NIV/2019-nCoV/Specimens_01
Prepared by: Dr. Y.K. Gurav Reviewed by: Dr. V. Potdar Approved by: Dr. P. Abraham
Date: 19/01/2020 Date: 20/01/2020 Date: 20/01/2020
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a vaccine and the three clinical trial phases.
This document outlines the...
Presentations and agenda of the meeting held to update industry on the COVAX Facility and Gavi’s support for cold chain equipment (CCE) for COVID-19 vaccines.
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...
Two test methods on dexamethasone tablets and injections
These are standing orders for eligible nurses and healthcare professionals to administer the Moderna COVID-19 vaccine to persons 18 years of age and older
This resource explains how WHO EUL COVID-19 vaccines without vaccine vial monitor or VVM should be handled at the vaccination site, to ensure that safe and potent vaccines are administered.
This document has been updated: 31 August 2021
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
